본문 바로가기
KERD
논문KCI 등재

Oncologic Outcomes of Extended Lymphadenectomy without Liver Resection for T1/T2 Gallbladder Cancer

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose: This study provides a standardized operative strategical algorithm that can be applied to patients with T1/T2 gallbladdercancer (GBC). Our aim was to determine the oncologic outcome of radical cholecystectomy with para-aortic lymph node dissectionwithout liver resection in T1/T2 GBC. Materials and Methods: From January 2005 to December 2017, 164 patients with GBC underwent operations by a single surgeonat Severance Hospital. A retrospective review was performed for 113 of these patients, who were pathologically determined to be instages T1 and T2 according to American Joint Committee on Cancer 7th guidelines. Results: Of the 113 patients, 109 underwent curative resection for T1/T2 GBC; four patients who underwent palliative operationswithout radical cholecystectomies were excluded from further analyses. For all T1b and T2 lesions, radical cholecystectomy withpara-aortic lymph node dissection was performed without liver resection. There were four GBC-related mortalities, and 5-yeardisease-specific survival was 97.0%. The median follow-up was 50 months (range: 5–145 months). In all T stages, the median wasnot reached for survival analysis. Five-year disease-specific survival for T1a, T1b, and T2 were 100%, 94.1%, and 97.1%, respectively. Five-year disease-free survival for T1a, T1b, and T2 were 100%, 87.0%, and 91.8%, respectively. Conclusion: Our results suggest that the current operative protocol can be applied to minimal invasive operations for GBC withsimilar oncologic outcomes as open approach. For T1/T2 GBC, radical cholecystectomy, including para-aortic lymph node dissection,can be performed safely with favorable oncologic outcomes.

Abstract

Purpose: This study provides a standardized operative strategical algorithm that can be applied to patients with T1/T2 gallbladdercancer (GBC). Our aim was to determine the oncologic outcome of radical cholecystectomy with para-aortic lymph node dissectionwithout liver resection in T1/T2 GBC. Materials and Methods: From January 2005 to December 2017, 164 patients with GBC underwent operations by a single surgeonat Severance Hospital. A retrospective review was performed for 113 of these patients, who were pathologically determined to be instages T1 and T2 according to American Joint Committee on Cancer 7th guidelines. Results: Of the 113 patients, 109 underwent curative resection for T1/T2 GBC; four patients who underwent palliative operationswithout radical cholecystectomies were excluded from further analyses. For all T1b and T2 lesions, radical cholecystectomy withpara-aortic lymph node dissection was performed without liver resection. There were four GBC-related mortalities, and 5-yeardisease-specific survival was 97.0%. The median follow-up was 50 months (range: 5–145 months). In all T stages, the median wasnot reached for survival analysis. Five-year disease-specific survival for T1a, T1b, and T2 were 100%, 94.1%, and 97.1%, respectively. Five-year disease-free survival for T1a, T1b, and T2 were 100%, 87.0%, and 91.8%, respectively. Conclusion: Our results suggest that the current operative protocol can be applied to minimal invasive operations for GBC withsimilar oncologic outcomes as open approach. For T1/T2 GBC, radical cholecystectomy, including para-aortic lymph node dissection,can be performed safely with favorable oncologic outcomes.

참고문헌 (25)

  1. Hueman MT, "Evolving treatment strategies for gallbladder cancer", Ann Surg Oncol, 16, pp.2101~2115 (2009)
  2. Lazcano-Ponce EC, "Epidemiology and molecular pathology of gallbladder cancer", CA Cancer J Clin, 51, pp.349~364 (2001)
  3. 이승은, "Practical Guidelines for the Surgical Treatment of Gallbladder Cancer", Journal of Korean Medical Science, 29(10), pp.1333~1340 (2014), 대한의학회
  4. Randi G, "Gallbladder cancer worldwide : geographical distribution and risk factors", Int J Cancer, 118, pp.1591~1602 (2006)
  5. Lee SE, "Systematic review on the surgical treatment for T1 gallbladder cancer", World J Gastroenterol, 17, pp.174~180 (2011)
  6. Kim DH, "Role of cholecystectomy and lymph node dissection in patients with T2 gallbladder cancer", World J Surg, 37, pp.2635~2640 (2013)
  7. Hoehn RS, "Adjuvant therapy for gallbladder cancer : an analysis of the National Cancer Data Base", J Gastrointest Surg, 19, pp.1794~1801 (2015)
  8. Ma N, "Adjuvant therapy in the treatment of gallbladder cancer : a meta-analysis", BMC Cancer, 15, pp.615~ (2015)
  9. Dindo D, "Classification of surgical complications : a new proposal with evaluation in a cohort of 6336patients and results of a survey", Ann Surg, 240, pp.205~213 (2004)
  10. Blalock A, "A statistical study of eight hundred and eighty-eight cases of biliary tract disease", Johns Hopkins Hosp Bull, 35, pp.391~409 (1924)
  11. Itano O, "Novel strategy for laparoscopic treatment of pT2 gallbladder carcinoma", Surg Endosc, 29, pp.3600~3607 (2015)
  12. Lee H, "Surgical strategy for T2 gallbladder cancer according to tumor location", Ann Surg Oncol, 22, pp.2779~2786 (2015)
  13. Zimmitti G, "Current role of minimally invasive radical cholecystectomy for gallbladder cancer", Gastroenterol Res Pract (2016)
  14. Yoon YS, "Is laparoscopy contraindicated for gallbladder cancer? A 10-year prospective cohort study", J Am Coll Surg, 221, pp.847~853 (2015)
  15. Kang CM, "Does “clinical” R0 have validity in the choice of simple cholecystectomy for gallbladder carcinoma?", J Gastrointest Surg, 11, pp.1309~1316 (2007)
  16. Ito M, "Lymphatic drainage of the gallbladder", J Hepatobiliary Pancreat Surg, 1, pp.302~308 (1994)
  17. Tsukada K, "Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage", Surgery, 120, pp.816~821 (1996)
  18. Ogura Y, "Radical operations for carcinoma of the gallbladder : present status in Japan", World J Surg, 15, pp.337~343 (1991)
  19. Kondo S, "Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma", Br J Surg, 87, pp.418~422 (2000)
  20. Lee H, "Optimal extent of surgery for early gallbladder cancer with regard to long-term survival : a meta-analysis", J Hepatobiliary Pancreat Sci, 25, pp.131~141 (2018)
  21. Sternby Eilard M, "Surgical treatment for gallbladder cancer–a systematic literature review", Scand J Gastroenterol, 52, pp.505~514 (2017)
  22. Woohyun Jung, "Effects of Surgical Methods and Tumor Location on Survival and Recurrence Patterns after Curative Resection in Patients with T2 Gallbladder Cancer", Gut and Liver, 10(1), pp.140~146 (2016), 거트앤리버 소화기연관학회협의회
  23. Horiguchi A, "Gallbladder bed resection or hepatectomy of segments 4a and 5 for pT2 gallbladder carcinoma : analysis of Japanese registration cases by the study group for biliary surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery", J Hepatobiliary Pancreat Sci, 20, pp.518~524 (2013)
  24. Pitt SC, "Incidental gallbladder cancer at cholecystectomy : when should the surgeon be suspicious", Ann Surg, 260, pp.128~133 (2014)
  25. Eltawil KM, "Neuroendocrine tumors of the gallbladder : an evaluation and reassessment of management strategy", J Clin Gastroenterol, 44, pp.687~695 (2010)

관련 논문AI추천

Effects of Surgical Methods and Tumor Location on Survival and Recurrence Patterns after Curative Resection in Patients with T2 Gallbladder Cancer신용찬, Jihoon Chang, Jin-Young Jang, Mee Joo Kang, Sun-Whe Kim, Woohyun Jung, Ye Rim Chang거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제1호Validation of the 8th Edition of the American Joint Committee on Cancer Staging System for Gallbladder Cancer and Implications for the Follow-up of Patients without Node Dissection황신, 성유나, 송기병, 송민정, 안철수, 이재훈, 홍승모, 황대욱대한암학회 · Cancer Research and Treatment2020 · 제52권 제2호Is There a Role for Adjuvant Therapy in R0 Resected Gallbladder Cancer?: A Propensity Score-Matched Analysis강정훈, 고세일, 김영생, 김은영, 박세훈, 박준오, 송하나, 오성용, 지준호, 황인규대한암학회 · Cancer Research and Treatment2016 · 제48권 제4호Stage Evaluation of Cystic Duct Cancer황신, 김예슬, 성유나, 유대광, 이경진, 이우형, 전선영, 정해성, 조형준, 홍승모대한암학회 · Cancer Research and Treatment2025 · 제57권 제2호Which Patients with Isolated Para-aortic Lymph Node Metastasis Will Truly Benefit from Extended Lymph Node Dissection for Colon Cancer?허혁, 김남규, 민병소, 배성욱, 백승혁, 이강영대한암학회 · Cancer Research and Treatment2018 · 제50권 제3호Validation of the Eighth American Joint Committee on Cancer Staging System for Distal Bile Duct Carcinoma박광민, 성유나, 이영주, 이재훈, 전선영, 홍승모대한암학회 · Cancer Research and Treatment2019 · 제51권 제1호

이 간행물의 다른 논문 (9건)